The Elton John AIDS Foundation (EJAF) announced today that it has selected British singer-songwriter Ed Sheeran to perform at this year's Academy Awards Viewing Party
The Elton John AIDS Foundation (EJAF) will present its 22 nd annual Academy Awards Viewing Party on Sunday, March 2, 2014 at West Hollywood Park in Los Angeles.
Hero Ventures, a Los Angeles based entertainment company, announced today that it is teaming up with Marvel Entertainment to create 'The Marvel Experience,' an innovative, traveling experience, featuring dozens of Marvel's iconic Super Heroes. This attraction will appeal to a multi-generational audience and will leverage state-of-the-art interactive and multimedia technology, including a 4D motion ride and original 3D animated features, allowing fans to be a part of the action. The tour comes to life in 2014.
When the critically-acclaimed business-themed show, “Shark Tank,” returns for a fifth season this fall, two guest tycoon businessmen and philanthropists will be diving into the tank alongside the Sharks
The Elton John AIDS Foundation (EJAF) announced today that it has selected soulful Scottish songstress Emeli Sandé to perform at this year's Academy Awards Viewing Party to be held on Sunday, February 24, 2013, at West Hollywood Park.
Stand Up To Cancer today announced that more than $81 million has been pledged so far in connection with its star-studded September 7 'roadblock' fundraising telecast to accelerate ground-breaking research and bring new treatments to patients as quickly as possible, including pediatric cancer patients through the creation of a new pediatric cancer research 'Dream Team.'
Stand Up To Cancer (SU2C) is proud to announce the Hollywood community is once again rallying together and lending its support to the third SU2C primetime television fundraising special on FRIDAY, SEPTEMBER 7 (8:00-9:00 p.m., ET/PT).
The Los Angeles County Museum of Art (LACMA) and the Academy of Motion Picture Arts and Sciences (The Academy) are pleased to co-present the first U.S. retrospective of filmmaker Stanley Kubrick, developed in collaboration with the Kubrick Estate and the Deutsches Filmmuseum, Frankfurt.
At last night's 23rd Annual GLAAD Media Awards, Cher and Congresswoman Mary Bono Mack (R-CA) presented the Stephen F. Kolzak Award to Chaz Bono, and Benicio Del Toro presented the Vanguard Award to Josh Hutcherson. Glee stars Max Adler and Grant Gustin presented the Rodemeyer family. Jamey Rodemeyer died by suicide at age 14 last year. Watch videos of the three award presentations below!
Two years after an historic fundraising telecast and the start of a groundbreaking grassroots movement, Stand Up To Cancer (SU2C) will return to primetime television on September 10, 2010, at 8PM EDT & PDT / 7PM CT, with a star-studded appeal to build continuing public support and donations for cutting-edge cancer research that translates at a rapid pace from the laboratory to treatments and technologies that benefit patients.
The Stand Up To Cancer (SU2C) television event is set to air live and commercial-free on FOX, September 10, 2010, at 8 p.m. EST & PST / 7 p.m. CST. Joining ABC, CBS and NBC, FOX will donate one hour of live simultaneous commercial-free primetime for the nationally televised September 10th fundraising special, to be broadcast from Los Angeles. Additionally, VH1, HBO Latino, TV One and G4 have agreed to air the SU2C event. They join HBO, Discovery Health, E!, MLB Network and The Style Network for an historic evening to raise much-needed funds for groundbreaking cancer research.
Thewrap.com reports today that Mike Nichols, Meryl Streep and Jeff Bridges may be teaming up on the film, Great Hope Springs. Deals are reportedly close to being signed, according to the report.
Two years after an historic fundraising telecast and the start of a groundbreaking grassroots movement, Stand Up To Cancer (SU2C) will return to primetime television on September 10, 2010, at 8PM EDT & PDT / 7PM CT, with a star-studded appeal to build continuing public support and donations for cutting-edge cancer research that translates at a rapid pace from the laboratory to treatments and technologies that benefit patients.